Cisplatin-induced apoptosis in auditory, renal, and neuronal cells is associated with nitration and downregulation of LMO4

Cell Death Discovery

Volumn 1, Issue 1, 2015, Pages

  Rathinam, R ^a   Ghosh, S ^b   Neumann, Wl ^c   Jamesdaniel, S ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84994623604     PISSN: None     EISSN: 20587716     Source Type: Journal    
DOI: 10.1038/cddiscovery.2015.52     Document Type: Article

References (38)

1. McKeage MJ. Comparative adverse effect profiles of platinum drugs. Drug Saf 1995; 13: 228–244.
2. Rubin JS, Wadler S, Beitler JJ, Haynes H, Rozenblit A, McGill F et al. Audiological findings in a phase I protocol investigating the effect of WR 2721, high-dose cisplatin and radiation therapy in patients with locally advanced cervical carcinoma. J Laryngol Otol 1995; 109: 744–747.
3. Skinner R, Pearson AD, English MW, Price L, Wyllie RA, Coulthard MG et al. Cisplatin dose rate as a risk factor for nephrotoxicity in children. Br J Cancer 1998; 77: 1677–1682.
4. Travis LB, Fossa SD, Sesso HD, Frisina RD, Herrmann DN, Beard CJ et al. Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics. J Natl Cancer Inst 2014; 106: pii: dju044.
5. Jamesdaniel S, Coling D, Hinduja S, Ding D, Li J, Cassidy L et al. Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4. J Biol Chem 2012; 287: 18674–18686.
6. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 2007; 226: 157–167.
7. More SS, Akil O, Ianculescu AG, Geier EG, Lustig LR, Giacomini KM. Role of the copper transporter, CTR1, in platinum-induced ototoxicity. J Neurosci 2010; 30: 9500–9509.
8. Karasawa T, Steyger PS. An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicol Lett 2015; 237: 219–227.
9. Kuhlmann MK, Burkhardt G, Kohler H. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 1997; 12: 2478–2480.
10. Avan A, Postma TJ, Ceresa C, Avan A, Cavaletti G, Giovannetti E et al. Platinum-induced neurotoxicity and preventive strategies: past, present, and future. Oncologist 2015; 20: 411–432.
11. Jamesdaniel S, Ding D, Kermany MH, Davidson BA, Knight PR 3rd, Salvi R et al. Proteomic analysis of the balance between survival and cell death responses in cisplatin-mediated ototoxicity. J Proteome Res 2008; 7: 3516–3524.
12. Mukhopadhyay P, Rajesh M, Pan H, Patel V, Mukhopadhyay B, Batkai S et al. Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy. Free Radic Biol Med 2010; 48: 457–467.
13. Giridharan VV, Thandavarayan RA, Bhilwade HN, Ko KM, Watanabe K, Konishi T. Schisandrin B, attenuates cisplatin-induced oxidative stress, genotoxicity and neurotoxicity through modulating NF-kappaB pathway in mice. Free Radic Res 2012; 46: 50–60.
14. Manetopoulos C, Hansson A, Karlsson J, Jonsson JI, Axelson H. The LIM-only protein LMO4 modulates the transcriptional activity of HEN1. Biochem Biophys Res Commun 2003; 307: 891–899.
15. Sum EY, Peng B, Yu X, Chen J, Byrne J, Lindeman GJ et al. The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity. J Biol Chem 2002; 277: 7849–7856.
16. Deng M, Pan L, Xie X, Gan L. Differential expression of LIM domain-only (LMO) genes in the developing mouse inner ear. Gene Expr Patterns 2006; 6: 857–863.
17. Deng M, Pan L, Xie X, Gan L. Requirement for Lmo4 in the vestibular morphogenesis of mouse inner ear. Dev Biol 2010; 338: 38–49.
18. Zaman T, Zhou X, Pandey NR, Qin Z, Keyhanian K, Wen K et al. LMO4 is essential for paraventricular hypothalamic neuronal activity and calcium channel expression to prevent hyperphagia. J Neurosci 2014; 34: 140–148.
19. Jamesdaniel S. Downstream targets of Lmo4 are modulated by cisplatin in the inner ear of Wistar rats. PLoS One 2014; 9: e115263.
20. Kaur T, Mukherjea D, Sheehan K, Jajoo S, Rybak LP, Ramkumar V. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation. Cell Death Dis 2011; 2: e180.
21. Gao S, Chen T, Choi MY, Liang Y, Xue J, Wong YS. Cyanidin reverses cisplatin-induced apoptosis in HK-2 proximal tubular cells through inhibition of ROS-mediated DNA damage and modulation of the ERK and AKT pathways. Cancer Lett 2013; 333: 36–46.
22. Donzelli E, Carfi M, Miloso M, Strada A, Galbiati S, Bayssas M et al. Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y. J Neurooncol 2004; 67: 65–73.
23. Rivolta MN, Halsall A, Johnson CM, Tones MA, Holley MC. Transcript profiling of functionally related groups of genes during conditional differentiation of a mammalian cochlear hair cell line. Genome Res 2002; 12: 1091–1099.
24. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 1994; 45: 48–57.
25. Bae EH, Choi HS, Joo SY, Kim IJ, Kim CS, Choi JS et al. Farnesoid X receptor ligand prevents cisplatin-induced kidney injury by enhancing small heterodimer partner. PLoS One 2014; 9: e86553.
26. Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK et al. SIRT1 overexpression decreases cisplatin-induced acetylation of NF-kappaB p65 subunit and cytotoxicity in renal proximal tubule cells. Biochem Biophys Res Commun 2012; 419: 206–210.
27. Ross RA, Spengler BA, Biedler JL. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 1983; 71: 741–747.
28. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 1978; 38 (11 Pt 1): 3751–3757.
29. Bollimuntha S, Singh BB, Shavali S, Sharma SK, Ebadi M. TRPC1-mediated inhibition of 1-methyl-4-phenylpyridinium ion neurotoxicity in human SH-SY5Y neuroblastoma cells. J Biol Chem 2005; 280: 2132–2140.
30. Sun YX, Yang J, Wang PY, Li YJ, Xie SY, Sun RP. Cisplatin regulates SH-SY5Y cell growth through downregulation of BDNF via miR-16. Oncol Rep 2013; 30: 2343–2349.
31. Doyle T, Chen Z, Muscoli C, Bryant L, Esposito E, Cuzzocrea S et al. Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain. J Neurosci 2012; 32: 6149–6160.
32. Gow AJ, Duran D, Malcolm S, Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett 1996; 385: 63–66.
33. Sanchez-Gonzalez PD, Lopez-Hernandez FJ, Perez-Barriocanal F, Morales AI, Lopez-Novoa JM. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity. Nephrol Dial Transplant 2011; 26: 3484–3495.
34. Hirst DG, Robson T. Nitrosative stress as a mediator of apoptosis: implications for cancer therapy. Curr Pharm Des 2010; 16: 45–55.
35. Jamesdaniel S, Manohar S, Hinduja S. Is S-nitrosylation of cochlear proteins a critical factor in cisplatin-induced ototoxicity? Antioxid Redox Signal 2012; 17: 929–933.
36. Wang N, Lin KK, Lu Z, Lam KS, Newton R, Xu X et al. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene 2007; 26: 6431–6441.
37. Tian Y, Wang N, Lu Z. Repression of Lim only protein 4-activated transcription inhibits proliferation and induces apoptosis of normal mammary epithelial cells and breast cancer cells. Clin Exp Metastasis 2010; 27: 455–463.
38. Rausaria S, Kamadulski A, Rath NP, Bryant L, Chen Z, Salvemini D et al. Manganese(III) complexes of bis(hydroxyphenyl)dipyrromethenes are potent orally active peroxynitrite scavengers. J Am Chem Soc 2011; 133: 4200–4203.